...
首页> 外文期刊>Gastroenterology research and practice >Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Ectasia: A Systematic Review of the Literature
【24h】

Radiofrequency Ablation for Treatment of Refractory Gastric Antral Vascular Ectasia: A Systematic Review of the Literature

机译:用于治疗难治性胃浴血管异构的射频消融:对文献的系统综述

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Study Aims. GAVE is an uncommon cause of upper nonvariceal bleeding and often manifests itself as occult bleeding with chronic anemia. To date, the standard of care for GAVE is endoscopic treatment with thermoablative techniques. Despite good technical results, approximately two thirds of patients remain dependent on transfusions after the therapy. One of the emerging and more promising endoscopic treatments for GAVE is radiofrequency ablation (RFA). The aim of this study is to perform a systematic review of literature in order to assess current evidence supporting the effectiveness of this technique for treatment of refractory GAVE. Materials and Methods. Through electronic search, we identified 14 records, and after removal of duplicates and irrelevant studies, we selected 10 studies on radiofrequency ablation of GAVE: 4 prospective open-label single-center studies, 1 retrospective multicentric study, and 5 case reports. Results. Among all 72 treated patients reported in literature, 74.3% achieved a clinical response, while nonfatal AEs have been reported in 4.2% of cases. Conclusions. Despite some qualitative limitations, all literature data support effectiveness of RFA for treatment of refractory GAVE. In the future, large prospective controlled trials with adequate follow-up are needed to better assess the effectiveness and safety of this procedure.
机译:背景和学习目标。给予上部非血糖出血的罕见原因,往往表现为具有慢性贫血的神秘血淋淋。迄今为止,给出的护理标准是具有热处理技术的内窥镜处理。尽管技术结果良好,但大约三分之二的患者仍然依赖于治疗后的输血。用于给予的新出现和更有前途的内窥镜治疗方法是射频消融(RFA)。本研究的目的是对文献进行系统审查,以评估支持该技术治疗难治性的该技术的有效性的现有证据。材料和方法。通过电子搜索,我们确定了14条记录,并在去除重复和无关的研究之后,我们选择了10项关于辐射杀灭射频消融的研究:4个潜在开放标签单中心研究,1回顾性多中心研究和5例报告。结果。在文献中报告的所有72名患者中,74.3%达到了临床反应,而非缺失的AES均为4.2%的病例报告。结论。尽管存在一些定性的限制,但所有文献数据支持RFA的有效性,用于治疗难治性。未来,需要具有充分随访的大型预期对照试验,以更好地评估该程序的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号